Long-term outcomes of percutaneous mitral balloon valvuloplasty versus open cardiac surgery

Jae-Kwan Song1, Mi-Jeong Kim, Sung-Cheol Yun

  • 1Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. jksong@amc.seoul.kr

Insights

Open heart surgery demonstrated superior long-term event-free survival compared to percutaneous mitral valvuloplasty. Patients with severe mitral valve disease or atrial fibrillation particularly benefited from open heart surgery.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Interventional Cardiology

Background:

  • Mitral valve disease is a significant cardiovascular condition.
  • Percutaneous mitral valvuloplasty (PMV) and open heart surgery (OHS) are primary treatment options.
  • Long-term comparative outcomes between PMV and OHS require further investigation.

Purpose of the Study:

  • To compare the long-term clinical outcomes of PMV versus OHS for mitral valve disease.
  • To identify patient subgroups that may benefit more from one procedure over the other.

Main Methods:

  • A cohort study evaluated 402 patients undergoing PMV and 159 patients undergoing OHS (1995-2000).
  • The primary endpoint was a composite of cardiovascular death or repeat intervention.
  • Outcomes were analyzed using Cox proportional hazards models, adjusting for baseline illness severity, echocardiographic scores, and cardiac rhythm.

Main Results:

  • Unadjusted event-free survival was similar between PMV and OHS groups.
  • Adjusted analysis revealed significantly higher event-free survival after OHS (adjusted hazard ratio: 3.729, P < .0001).
  • Patients with high echocardiographic scores (≥8) or atrial fibrillation showed substantially better outcomes with OHS (adjusted hazard ratios: 5.348 and 3.440, respectively).

Conclusions:

  • Open heart surgery is associated with superior long-term event-free survival compared to percutaneous mitral valvuloplasty.
  • OHS offers better long-term outcomes for patients with significant echocardiographic abnormalities or atrial fibrillation.
  • Patient selection based on disease severity and comorbidities is crucial for optimizing mitral valve intervention outcomes.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...